Hemophilia A Research Program (HARP) Education/ LinkedIn
Jul 22, 2026, 09:46
Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
Hemophilia A Research Program (HARP) Education shared a post on LinkedIn:
“The HARP mother-baby study in hemophilia is recruiting! Please help us get the word out!
Interested pregnant moms can go to HARP.
Providers can directly refer at: [email protected]
Flyers can also be downloaded at HARP Resources.
Hemophilia A Research Program (HARP) is looking to reach pregnant mothers anywhere in the U.S. Eligible moms have a genotype that causes hemophilia A (sometimes known as ‘carriers’) and a baby potentially at-risk for severe hemophilia A.
HARP is studying hemophilia bleeding risk in pregnancy and the causes of inhibitor formation in early childhood. To learn more visit HARP and Clinical Trials.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome